Text Size
2 studies found for:    OMP-59R5

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Phase 1b/2 Study of OMP-59R5 in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: OMP-59R5;   Drug: Gemcitabine;   Drug: Placebo;   Drug: Nab-Paclitaxel
2 Active, not recruiting A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
Condition: Solid Tumors
Intervention: Drug: OMP-59R5
To Top

† Indicates status has not been verified in more than two years